Genetic counselors, who help people navigate tests, have concerns about how those who have taken the test will interpret their results.

Regeneron Pharmaceuticals on Monday announced plans to purchase genetic testing company 23andMe for $256 million. The New York-based drugmaker is set to take over 23andMe after winning a bankruptcy ...

Genetic testing company 23andMe, once valued at $6 billion, has filed for bankruptcy. State attorneys general are urging concerned customers to delete their data, while experts warn that state and ...

New York-based biotech giant Regeneron Pharmaceuticals announced May 19 its plan to purchase the bankrupt genetic testing firm 23andMe in a $256 million deal that could include millions of Americans' ...

Drugmaker Regeneron Pharmaceuticals will buy genetic testing firm 23andMe for $256 million through a bankruptcy auction, the companies said Monday. Regeneron said it will comply with 23andMe’s privacy ...

Experts caution those using these services to be careful, as you may not always get what you want from biological relatives.

Consumer DNA testing kits like 23andMe and AncestryDNA aren’t just making it easier to uncover your heritage or track down ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. NEW YORK (AP) — All of 23andMe’s independent ...

The Food and Drug Administration has issued a severe warning to DIY DNA testing firm 23andMe, telling the company to stop advertising its at-home genetic testing kit that the feds say is misleading, ...

Genetic testing company 23andMe, once valued at $6 billion, has filed for bankruptcy. State attorneys general are urging concerned customers to delete their data, while experts warn that state and ...